Related Experiment Video
Updated: May 3, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Essential role for the p110delta phosphoinositide 3-kinase in the allergic response
Khaled Ali1, Antonio Bilancio, Matthew Thomas
1Ludwig Institute for Cancer Research, 91 Riding House Street, London W1W 7BS, UK.
Abstract:
Inflammatory substances released by mast cells induce and maintain the allergic response. Mast cell differentiation and activation are regulated, respectively, by stem cell factor (SCF; also known as Kit ligand) and by allergen in complex with allergen-specific immunoglobulin E (IgE). Activated SCF receptors and high-affinity receptors for IgE (FcvarepsilonRI) engage phosphoinositide 3-kinases (PI(3)Ks) to generate intracellular lipid second messenger signals. Here, we report that genetic or pharmacological inactivation of the p110delta isoform of PI(3)K in mast cells leads to defective SCF-mediated in vitro proliferation, adhesion and migration, and to impaired allergen-IgE-induced degranulation and cytokine release. Inactivation of p110delta protects mice against anaphylactic allergic responses. These results identify p110delta as a new target for therapeutic intervention in allergy and mast-cell-related pathologies.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Amplifying Signals via Second Messengers
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
IP3/DAG Signaling Pathway

